Estats Units - anglès - NLM (National Library of Medicine)

viatrexx bio incorporated - androsterone (30k), artichoke (30k), atp (30k), bfgf (6x, 200k), camp (30k), l-carnitine (30k), centella asiatica (6x, 30k), citric acid (30k), cobalt (30k), estrogen (200k), ferrum fumaricum (30k), fumaric acid (30k), ginkgo (30k), hamamelis (30k), hyaluronidase (4x, 30k), il-3 (8x, 200k), kalium asparticum (30k), lactic acid (30k), lymphatic vessel (8x, 200k), melilotus (30k), mn (30k), natrum oxalaceticum (30k), natrum pyruvicum (30k), quinhydrone (30k), succinic acid (30k), vein (6x, 200k), vitamin a (3 - cellulite drainage & tonification, metabolism and lipid balance, hormonal support, circulatory support and regeneration. 

Estats Units - anglès - NLM (National Library of Medicine)

viatrexx bio incorporated - sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), bos taurus adrenal gland (unii: m2776swb29) (bos taurus adrenal gland - unii:m2776swb29), azelaic acid (unii: f2vw3d43yt) (azelaic acid - unii:f2vw3d43yt), bos taurus skin (unii: 7j12cd6o9l) (bos taurus skin - unii:7j12cd6o9l), copper (unii: 789u1901c5) (copper - unii:789u1901c5), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), fumaric acid (unii: 88xhz13131) (fumaric acid - unii:88xhz13131), glutathio - skin issues

Estats Units - anglès - NLM (National Library of Medicine)

viatrexx bio incorporated - echinacea angustifolia (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), sus scrofa thymus (unii: 7b69b0bd62) (sus scrofa thymus - unii:7b69b0bd62), bos taurus thymus (unii: 8xej88v2t8) (bos taurus thymus - unii:8xej88v2t8), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds), berbe - nutritional support for fungal, mold, bacteria challenges 

Estats Units - anglès - NLM (National Library of Medicine)

viatrexx bio incorporated - calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), centella asiatica (unii: 7m867g6t1u) (centella asiatica - unii:7m867g6t1u), copper (unii: 789u1901c5) (copper - unii:789u1901c5), sus scrofa embryo (unii: 9928mc12vo) (sus scrofa embryo - unii:9928mc12vo), human embryo tissue (unii: 8n9p319h5s) (human embryo tissue - unii:8n9p319h5s), fumaric acid (unii: 88xhz13131) (fumaric acid - unii:88xhz13131), bos taurus umbilical cord (unii: e2lc2a33sn) (bos taurus umbilical cord - unii:e2lc - soft tissue regeneration.

Estats Units - anglès - NLM (National Library of Medicine)

viatrexx bio incorporated - nadide (unii: 0u46u6e8uk) (nadide - unii:0u46u6e8uk) -

Canadà - anglès - Health Canada

servier canada inc - pralatrexate - solution - 20mg - pralatrexate 20mg - antineoplastic agents

Canadà - anglès - Health Canada

servier canada inc - pralatrexate - solution - 40mg - pralatrexate 40mg - antineoplastic agents

Estats Units - anglès - NLM (National Library of Medicine)

acrotech biopharma inc - pralatrexate (unii: a8q8i19q20) (pralatrexate - unii:a8q8i19q20) - folotyn is indicated for the treatment of patients with relapsed or refractory peripheral t-cell lymphoma (ptcl). this indication is approved under accelerated approval based on overall response rate [see clinical studies (14)] . continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). none risk summary based on findings from animal studies and its mechanism of action [see clinical pharmacology (12.1)] , folotyn can cause fetal harm when administered to a pregnant woman. there are insufficient data on folotyn use in pregnant women to evaluate for a drug- associated risk. folotyn was embryotoxic and fetotoxic in rats and rabbits when administered during organogenesis at doses about 1.2% (0.012 times) of the clinical dose on a mg/m2 basis. advise pregnant women of the potential risk to a fetus. the estimated background risk of major birth defects and miscarriage for the indicated population(s) is unknown. all pregnancies have

Singapur - anglès - HSA (Health Sciences Authority)

mundipharma pharmaceuticals pte. ltd. - pralatrexate - infusion, solution - 20mg/ml - pralatrexate 20mg/ml

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

opus -